Table 1.
Characteristic | 60 to <65 n = 78 (23.6%) | 65 to <70 n = 94 (28.6%) | 70 to <75 n = 76 (23.0%) | ≥75 n = 82 (24.8%) | Statistics |
---|---|---|---|---|---|
| |||||
Age, yrs, mean (SD) | 62.1 (1.6) | 67.3 (1.5) | 72.4 (1.3) | 78.8 (3.2) | |
| |||||
Age range, yrs | 60 to 64 | 65 to 69 | 70 to 74 | 75 to 86 | |
| |||||
% | % | % | % | ||
| |||||
Study project | |||||
Fatigue, Pain, and Sleep | 37.2 | 28.7 | 26.3 | 23.2 | |
Symptom Prevalence | 24.4 | 34.0 | 34.2 | 32.9 | NS |
Symptom Clusters | 38.5 | 37.2 | 39.5 | 43.9 | |
| |||||
Gender, female | 41.0 | 41.5 | 43.4 | 41.5 | NS |
| |||||
Lives alone | 28.6 | 27.2 | 28.9 | 28.4 | NS |
| |||||
Married/partnered | 64.1 | 64.5 | 64.0 | 62.2 | NS |
| |||||
Education – Post high school | 53.9 | 54.3 | 58.1 | 55.7 | NS |
| |||||
Diagnosis | |||||
Breast | 28.2 | 23.4 | 21.1 | 14.6 | |
Prostate | 38.5 | 32.7 | 34.2 | 41.5 | NS |
Lung | 10.3 | 12.8 | 22.4 | 13.4 | |
Other | 23.1 | 26.6 | 22.4 | 30.5 | |
| |||||
Metastasis | 22.4 | 30.4 | 43.4 | 34.1 | NS |
| |||||
Treatment | |||||
None | 12.8 | 16.1 | 14.5 | 25.6 | |
Only radiation | 52.6 | 50.5 | 52.6 | 50.0 | NS |
Only chemotherapy | 24.4 | 25.8 | 25.0 | 22.0 | |
Both | 10.3 | 7.5 | 7.9 | 2.4 | |
| |||||
ECOG Performance Status | |||||
Fully active | 30.8 | 26.1 | 24.3 | 22.8 | |
Ambulatory, light work | 43.6 | 48.9 | 44.6 | 44.3 | |
Ambulatory, mobile >50% | 19.2 | 20.7 | 20.3 | 20.3 | NS |
Ambulatory mobile <50% | 6.4 | 4.3 | 8.1 | 12.7 | |
Disabled | 0.0 | 0.0 | 2.7 | 0.0 |
SD = standard deviation; ECOG = Eastern Cooperative Oncology Group.